Walgreens is closing roughly 100 stores and eliminating 628 corporate and warehouse jobs this year, the latest contraction at a chain that has spent two years shrinking its national footprint. The layoffs are concentrated in two states, and each shuttered pharmacy pushes its customers to move prescriptions to a nearby location. For older shoppers who rely on one familiar counter for medications, vaccinations, and blood-pressure checks, the closures raise a practical question that outlives any single earnings report: how far the closest open pharmacy now sits, and whether a maintenance drug will still be waiting on refill day.
The 628 job cuts center on a shuttered Houston distribution center
The headline layoff number is unusually specific because it comes from formal state notices rather than an executive’s estimate. Of the 628 positions, 469 sit in Illinois, Walgreens’ home state, and the remaining 159 are in Texas, where the company is winding down a distribution center near Houston. The Texas cuts are scheduled to take effect around the start of June, and warehouse roles rarely transfer cleanly to a retail floor, which means most of those workers are looking for new employers rather than new departments.
The retrenchment follows a change of ownership that reset expectations for the entire company. In 2025 the private equity firm Sycamore Partners bought Walgreens for roughly $10 billion and took it private, ending its long run as a publicly traded stock. A privately held Walgreens answers to a buyout firm focused on cost and cash flow, and a distribution center that no longer fits a smaller store network becomes an early target. Watchdogs that track private equity in health care flagged the 628-job reduction and the facility closure as a sign of that pressure reaching the supply chain.
Free retirement updates: Want plain-English help keeping more of your money in retirement? The free Retirement Shield newsletter covers the benefits, deadlines, and money mistakes that cost retirees, a couple times a week. Subscribe free.
The store closures extend a retreat that began before the buyout
The store count is smaller than earlier alarms suggested. Walgreens now expects to close fewer than 100 locations in 2026, well below internal projections that had once approached 700 for the year. That figure sits inside a longer plan the company announced in 2024 to shutter about 1,200 underperforming stores through 2027, so the current round is one installment of a multiyear pullback rather than a sudden collapse. Reporting on the widening job cuts and store closures describes a company still recalibrating how many corners it can profitably occupy.
The math behind the closures is not mysterious. Retail pharmacy margins have been squeezed by low reimbursement on filled prescriptions, front-of-store sales lost to online sellers and big-box competitors, and, in some markets, persistent theft. When a location cannot cover its own rent and staffing from those thinning margins, closing it and folding its prescription volume into a nearby store is the arithmetic a cost-focused owner runs first.
Walgreens is also not contracting alone, which is what makes a single closure harder to backfill. CVS has been working through its own multiyear plan to close hundreds of locations, and Rite Aid moved through bankruptcy and wound down or sold off much of its store base, so a neighborhood that loses a Walgreens cannot always count on a rival chain a block away to absorb the demand. When several chains retrench in the same market at once, the surviving pharmacies inherit more prescription volume, which is the mechanism behind the longer counter waits and stock shortages customers notice after a nearby store goes dark.
A transferred prescription is not always a convenient one
When a Walgreens closes, its prescription files are generally reassigned to another company pharmacy nearby, and refills continue under the same insurance without a new doctor’s order. That transfer is automatic on paper, but it can move a standing prescription several miles or into a busier store with longer waits, a real cost for a customer who does not drive at night or who fills a stack of maintenance medications every month. Coverage of the specific stores on the closure list underscored that the impact depends heavily on which neighborhoods lose a branch.
The stakes are highest in places already thin on options. In rural counties and lower-income urban blocks, a single drugstore can be the only pharmacy for miles, and its closure can leave residents in what public-health researchers call a pharmacy desert. An affected shopper should confirm where a closing store is sending its records, whether a preferred medication is stocked at the receiving location, and whether a mail-order option through the same insurer would spare the trip entirely.
The automatic transfer also has limits worth knowing before refill day. Prescriptions for controlled substances, a category that includes many pain, anxiety, and ADHD medications, generally cannot be moved on a pharmacy’s own initiative the way an ordinary maintenance drug can, and may require a fresh order from the prescriber, which introduces a gap for anyone who waits until the last pill. Switching a 90-day supply or a specialty medication to a receiving store can also run into stocking differences, since not every branch keeps the same drugs on hand. Confirming those details ahead of time is the difference between a seamless handoff and a stretch of days without a needed medication.
None of the 628 layoffs or the store closures signal that Walgreens is disappearing, but together they mark how far the retail-pharmacy model has bent under private ownership and margin pressure. The chain that once measured success by planting a store on every busy corner is now measuring it by which corners it can afford to keep, and for the customers on the wrong side of that calculation, the nearest counter just moved.
This article was produced with AI assistance and reviewed against primary sources by The Money Overview editorial team.
More Financial Reading
